Dear collective,
A colleague saw a commercial rep this week who discussed the topic of aspirin resistance and its assessment by an automated urinary assay (Randox ‘TxB Cardio’). Is anyone else evaluating this, and indeed do we need to consider assessing aspirin-resistant patients ?!
Philip
P A Hyde (Mr)
Consultant Clinical Biochemist,
Dept Clinical Biochemistry,
Boston site (Path Links),
Pilgrim Hospital,
Boston PE21 9QS (UK)
Tel : 01205-446339 (ext) or ex 6339 (int)